Salmonella enterica
Cell therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2021 (NCT05038150)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05103345 | Phase 1 | Mar 31, 2022 | Guangzhou Sinogen Pharmaceutical Co., Ltd |
| NCT05038150 | Phase 1 | Oct 31, 2021 | Guangzhou Sinogen Pharmaceutical Co., Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guangzhou Sinogen Pharmaceutical Co., Ltd | For profit | 2 | 2 | 1 | 2021 |
1 organizations
Page 1 / 1